This free, one-day interactive event provides an opportunity to discuss and debate cutting edge research with scientists, patients, research students and clinicians/nurses, and to think about the impact that this research has on society and on you.
Lentviral and retroviral vectors are at the forefront of advanced therapeutic medicinal product (ATMP) development. The 1-day conference in April 2018 aims to give the attendee an overview about the successes, challenges and areas for future development.
Following the success of our recent BSGCT conferences in Glasgow and London, the date for the Annual Conference in 2017 will be Wednesday 19th to Friday 21st April to be held at the Royal Welsh College of Music and Drama, Cardiff, Wales.
Dedicating to facilitating education, communication and the sharing of expertise and knowledge.
The aim of the British Society for Gene and Cell Therapy is to accelerate scientific progress and promote ethical and efficient transfer of gene- and cell-based technologies from the laboratory into the clinic.
Gene and cell therapy is an area where co-operation between ALL the interested parties - general public, patients, scientists, government and the media - is vital for the optimal development of these technologies and treatments, and BSGCT is working towards becoming this pro-active interface.